Complete remission of NUP98 fusion-positive acute myeloid leukemia with the covalent menin inhibitor BMF-219, icovamenib

Affiliations

Hetty E. Carraway: Department of Hematology and Medical Oncology, Taussig Cancer Center Institute, Cleveland Clinic, Cleveland, OH
Joy Nakitandwe: Department of Pathology and Laboratory Medicine, Diagnostics Institute, Cleveland Clinic, Cleveland OH
Alexandru Cacovean: Biomea Fusion, Inc., Redwood City, CA
Yan Ma: Biomea Fusion, Inc., Redwood City, CA
Brian Munneke: Biomea Fusion, Inc., Redwood City, CA
Ganesh Waghmare: Biomea Fusion, Inc., Redwood City, CA
Clarissa Mandap: Biomea Fusion, Inc., Redwood City, CA
Uzma Ahmed: Biomea Fusion, Inc., Redwood City, CA
Nicole Kowalczyk: Biomea Fusion, Inc., Redwood City, CA
Thomas Butler: Biomea Fusion, Inc., Redwood City, CA
Stephan W. Morris: Biomea Fusion, Inc., Redwood City, CA

Abstract

Not available.

ISSN: 0390-6078 (Print); 1592-8721 (Online)
Publisher: Ferrata Storti Foundation
Country of publisher: Italy
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.haematologica.org